← Leaderboards
Mamoun M Alhamadsheh
University Of The Pacific-Stockton
$1,684,550
Attributed
$1,684,550
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $372.7K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,684,550 · 3
By mechanism
R01$1,012,500 · 1
R15$672,050 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignRattusPrealbuminLigandsDrug KineticsSeriesSerum ProteinsSerumIn VitroIn VivoDoseBindingToxic EffectDrug Delivery SystemsRenal Clearance FunctionPharmaceutical PreparationsMetabolicHydrophilicityFundingHydrolysisAntagonistAdverse EffectsAmericanEfficacy Evaluation
Grant awards (5)
A novel drug delivery system for the prevention and rescue of fentanyl and other opioid overdoses$337,500
R01 · FY2025 · DA · contact PI
A novel drug delivery system for the prevention and rescue of fentanyl and other opioid overdoses$337,500
R01 · FY2024 · DA · contact PI
A novel drug delivery system for the prevention and rescue of fentanyl and other opioid overdoses$337,500
R01 · FY2023 · DA · contact PI
A new and improved drug delivery system for targeting cancer$372,731
R15 · FY2018 · GM · contact PI
Harnessing transthyretin to extend the in vivo half-life of therapeutic peptides$299,319
R15 · FY2014 · GM · contact PI